HUDSON, Wisc. – Phillips-Medisize, a Molex company, has joined forces with health care software provider InterSystems to develop a third-generation connected health platform that enables pharmaceutical companies to connect medication and diagnostic information across their drugs and therapy areas in a single platform. The integration of InterSystems HealthShare will offer an information-sharing and analytics platform designed for connected drug delivery devices, biosensors and regulated Mobile Medical Applications (SaMD/MMA). “Our collaboration with InterSystems brings together the information that matters—connecting pharmaceutical companies, providers, patients and payers on the Phillips-Medisize Connected Health Platform—through a unified healthcare medication record and powerful analytics that span the care continuum,” said Matt Jennings, CEO and president of Phillips-Medisize, in a statement. Data collected by connected devices using the Phillips-Medisize Connected Health Platform can be shared securely to inform the patient and their health care provider when medications have been administered, and can be combined with data from diagnostic devices and biometric sensors to generate further insights. Pharmaceutical companies working with Phillips-Medisize will receive an exclusive, secure private cloud. “The collaboration between InterSystems and Phillips-Medisize aims to change the paradigm with a highly scalable platform to securely connect and aggregate data from rare diseases to many millions of patients across global geographies, encouraging patients in the most effective use of prescribed medications to improve outcomes,” said Don Woodlock, head of the HealthShare business unit at InterSystems, in a statement.
You are here: / / Phillips-Medisize, InterSystems partner on connected health platform